InMode Ltd. - Ordinary Shares (NQ:INMD)

13.99 -0.14 (-0.99%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InMode Ltd. - Ordinary Shares

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

3 Healthcare Stocks That Could Help Make You a Fortune ↗

April 24, 2023

These companies are top players in their fields.

Via The Motley Fool

3 Exceptional Growth Stocks You Can Buy Now With $200 and Hold Forever ↗

April 22, 2023

It doesn't take much to get your money to start working for you in the stock market.

Via The Motley Fool

A Look At Inspire Medical And InMode ↗

April 20, 2023

An analysis of two stocks in the medical device field.

Via Talk Markets

Stock Market Rally Mixed Amid Recession Worries; JPMorgan Headlines Earnings: Weekly Review ↗

April 14, 2023

The Nasdaq was flat while the Dow rose amid rising recession fears.

Via Investor's Business Daily

Why InMode Shares Are Trading Higher Today ↗

April 12, 2023

InMode Ltd. (NASDAQ: INMD) shares are trading higher on Wednesday after the company issued Q1 guidance. According to the guidance, InMode expects Q1 revenue of $105.7 million - $105.9 million, non-GAAP...

Via Benzinga

InMode (INMD) Q4 2022 Earnings Call Transcript ↗

February 14, 2023

INMD earnings call for the period ending December 31, 2022.

Via The Motley Fool

InMode Slumps On Light Earnings Outlook Despite Quarterly Beat ↗

February 14, 2023

The company continued its trend of beating already strong quarterly expectations.

Via Investor's Business Daily

3 Reasons Wall Street Thinks InMode Can Rocket 47% Higher in 2023 ↗

January 27, 2023

Analysts' price targets for this stock suggest it could soon put up some big gains.

Via The Motley Fool

InMode Soars On Bullish Pre-Announcement — But There's A Slight Caveat ↗

April 12, 2023

One analyst questions whether InMode will be able to maintain its rapid clip.

Via Investor's Business Daily

Bunge, InMode, And A Chinese Fortune 500 Fast-Food Restaurant Company On CNBC's 'Final Trades' ↗

April 11, 2023

On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management picked InMode Ltd. (NASDAQ: INMD), which is an American technology company.

Via Benzinga

5 Top Growth Stocks to Buy Before the Next Bull Market ↗

April 06, 2023

Now is the time to prepare your portfolio for better days ahead.

Via The Motley Fool

Could These 2 Growth Stocks Outperform Amazon in 2023? ↗

March 29, 2023

Analysts think both stocks could beat Amazon, but for one company, the case is dubious.

Via The Motley Fool

Got $100? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond ↗

March 22, 2023

These stocks are ripe for a rebound.

Via The Motley Fool

2 Exceptional Growth Stocks That Could Jump 37.6% to 40.2% Higher, According to Wall Street ↗

March 08, 2023

These businesses are at the top of their respective industries, but you wouldn't know it by looking at their stock prices.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 ↗

March 29, 2023

Via Benzinga

10 Best Stocks to Buy Now -- Growth Stocks at a Reasonable Price ↗

March 04, 2023

These 10 best stocks will add growth, dividends, and diversification to your long-term investment portfolio.

Via The Motley Fool

Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential ↗

March 02, 2023

There isn't much that's stopping them from penetrating their markets globally.

Via The Motley Fool

Target, InMode, Wynn Resorts And This US Bank Is A 'Favorite' In Financial Sector: CNBC's 'Final Trades' ↗

March 01, 2023

On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management said InMode Ltd. (NASDAQ: INMD) trades at 13 times next year's earnings.

Via Benzinga

2 High-Growth Stocks That Could Double Your Money in 5 Years or Less ↗

February 28, 2023

Both are likely to double quite soon, and they aren't even that risky.

Via The Motley Fool

Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023 ↗

February 28, 2023

Both have growth catalysts on the way, and plenty of recurring revenue too.

Via The Motley Fool

3 Under-the-Radar Growth Stocks with Promising Fundamentals ↗

February 23, 2023

Maximize your chances of success in the stock market by investing in these under-the-radar growth stocks that are trading at a discount.

Via InvestorPlace

Analyst Says M&A Could Be A Negative Catalyst For This Aesthetic Company ↗

February 17, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023 ↗

February 17, 2023

Via Benzinga

2 Terrific Growth Stocks to Buy With $200 Right Now ↗

February 16, 2023

You don't have to be rich to get your money to start working for you.

Via The Motley Fool

Better Medtech Stock to Buy: InMode or Outset Medical? ↗

February 15, 2023

Here are the "ins and outs" for these two stocks.

Via The Motley Fool

InMode's Q4 Earnings Surpass Expectations, Issues Mixed FY23 Guidance ↗

February 14, 2023

Via Benzinga

What's Going On With InMode Stock Today? ↗

February 14, 2023

InMode Ltd (NASDAQ: INMD) shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings f

Via Benzinga

3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street ↗

February 12, 2023

Find out why the investment bankers who follow these stocks think they can soar in the near term.

Via The Motley Fool

3 No-Brainer Growth Stocks to Buy in 2023 ↗

February 03, 2023

These stocks all fell by double digits last year.

Via The Motley Fool

Earnings Scheduled For February 14, 2023 ↗

February 14, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.